Updated:
MMJ Group Holdings Ltd
MMJ Group Holdings Ltd is an ASX-listed Australian investment firm pivoting from cannabis into psychedelics and real estate. Sydney-based.
MMJ Group Holdings Ltd
MMJ Group Holdings Ltd began as a cannabis-focused investor, listed on the Australian Securities Exchange under the ticker MMJ, and later widened its mandate to include psychedelics and real estate. The firm operates as a holding company, deploying capital across public equities, direct investments, and physical property. Its portfolio spans drug-development companies such as GH Research, which is evaluating me thylone for treatment-resistant depression, and property assets including a former cannabis cultivation site in California. Geographically, MMJ Group holds positions in North America and Australia, with a focus on regulated and therapeutic markets. The firm has no publicly disclosed AUM or team size, and its listed structure provides liquidity not typical of traditional family offices. No recent operational events were found in the public domain. MMJ Group's structural differentiator is its ASX listing, which allows investors outside the founding family to participate in what is essentially a thematic venture portfolio. That public-market governance — quarterly reporting, continuous disclosure — creates a transparency posture rare among private family investment offices.
General information
Firm type
Family Office
Year founded
—
AUM
Undisclosed
Location
Region
Oceania
Country
Australia
City
Sydney
Corporate office
Sydney, Australia
Sector focus
Frequently asked questions
Who runs investment decisions at MMJ Group Holdings Ltd?
Public filings list directors and executives, but the firm has not disclosed a named investment committee. Given its ASX listing, governance follows corporate rather than single-family-office norms — decisions are made by a board accountable to shareholders.
Is MMJ Group Holdings a single family office or a listed investment firm?
It is an ASX-listed public company that self-describes as an investment firm. While its founding capital likely came from a family group, its structure subjects it to continuous disclosure and shareholder oversight, distinguishing it from private family offices.
What investment stages does MMJ Group typically target?
The firm holds both public equities and direct positions in mid-to-late-stage private drug-development companies, plus real estate. It does not appear to invest in early-stage venture rounds or provide seed capital.
How does MMJ Group source proprietary deal flow?
No public information describes its sourcing model. As a listed entity, it may rely on public advisory networks and board connections rather than proprietary topping rights from a family network.
Does MMJ Group primarily invest in cannabis or psychedelics?
Since 2020 the firm has shifted its public emphasis from cannabis cultivation toward psychedelics drug-development and real estate. Its portfolio includes therapeutic drug companies rather than cultivation or retail cannabis assets (per public record, 2023).
Where does MMJ Group's underlying wealth come from?
The firm is a listed public company, so its capital base comes from shareholders. The original founding capital source has not been attributed to a specific family or individual fortune in the public record.
Does MMJ Group pay dividends to shareholders?
The firm has not paid a dividend in recent years, reinvesting cash flow into portfolio holdings. Its stated goal is capital appreciation from the growth of its investee companies.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: